1Zandi-Nejad K, Luyckx V A, Brenner B M. Adult hypertension and kidney disease : the role of fetal programming [ J ]. Hypertension, 2006, 47 (3) : 502-508.
3Bellamy L, Casas J P, Hingorani A D, et al. Preeclampsia and risk of cardiovascular disease and cancer in later life: systemat- ic review and meta-analysis [ J ]. BMJ, 2007, 335 ( 7627 ) : 974-985.
4Craid I M, Wagna S J, Haman S R, et al. Preeclampsia preg- nancies : an opportunity to identify women at risk for future car- diovascular disease [ J ]. Womens Health ( Lonol Engl ) , 2008, 4(2) : 133-135.
5Lykke J A, Langhoff-Roos J, Sibai B M, et al. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and Type 2 diabetes mellitus in the mother [ J]. Hypertension, 2009, 53(6) : 944-951.
6Lindheimer M D, Romero R. Emerging roles of antiangiogenic and angiogenic proteins in pathogenesis and prediction of pre- eclampsia [J]. Hypertension, 2007, 50(7): 35-36.
7Levine R J, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia [ J]. N Engl J Med, 2006, 355 (10) : 992-1005.
8Elena V K, Carma A, William M C. Hypertensive disorders and severe obstetric morbidity in the United States [ J ]. Obstet- Gynecol, 2009, 113(6) : 1299-1306.
9Conde-Agudelo A, Belizan J M. Risk factors for preeclampsia in a large cohort of Latin American and Caribbean women [ J ]. BJOG, 2000, 107( 1 ) : 75-83.
10Duckitt K, Harrington D. Risk factors for preeclampsia at ante- natal booking: systematic review of controlled studies [ J]. BMJ, 2005, 330(7491 ): 565-566.
